Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognosis-related genes participate in immunotherapy of renal clear cell carcinoma possibly by targeting dendritic cells. | Front Cell Dev Biol | 2022 | 36247009 | PubTator, text mining | PubMed |
| Construction of Prognostic Risk Model for Small Cell Lung Cancer Based on Immune-Related Genes. | Comput Math Methods Med | 2022 | 36245844 | PubTator, text mining | PubMed |
| High expression of glycolysis-related PGM2 gene in relation to poor prognosis and deficient immune cells infiltration in lung adenocarcinoma: a study based on bioinformatics analysis. | J Thorac Dis | 2022 | 36245582 | PubTator, text mining | PubMed |
| Co-expression network analysis identifies potential candidate hub genes in severe influenza patients needing invasive mechanical ventilation. | BMC Genomics | 2022 | 36243706 | PubTator, text mining | PubMed |
| RIPK3 modulates sarcoma through immune checkpoint HAVCR2. | Oncol Lett | 2022 | 36238358 | PubTator, text mining | PubMed |
| Construction of a competing endogenous RNA network in head and neck squamous cell carcinoma by pan-cancer analysis. | Transl Cancer Res | 2022 | 36237258 | PubTator, text mining | PubMed |
| Single-Cell Gene Expression Analysis Revealed Immune Cell Signatures of Delta COVID-19. | Cells | 2022 | 36230912 | PubTator, text mining | PubMed |
| Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma. | Cancers (Basel) | 2022 | 36230815 | PubTator, text mining | PubMed |
| Noncoding RNAs-mediated overexpression of KIF14 is associated with tumor immune infiltration and unfavorable prognosis in lung adenocarcinoma. | Aging (Albany NY) | 2022 | 36227151 | PubTator, text mining | PubMed |
Analysis of Data on Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy for Chronic Lymphocytic Leukemia Shows High Patient Heterogeneity and the Need for More Consideration of Individualized Treatment. | Comput Math Methods Med | 2022 | 36226246 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the clinical significance of HLA class II in breast cancer. | Medicine (Baltimore) | 2022 | 36221383 | PubTator, text mining | PubMed |
| A statistical physics approach for disease module detection. | Genome Res | 2022 | 36220609 | PubTator, text mining | PubMed |
| Isolated Pre-existing HLA-DP Donor-Specific Antibodies are Associated With Poorer Outcomes in Renal Transplantation. | Kidney Int Rep | 2022 | 36217531 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related lncRNAs for patients with colon adenocarcinoma. | Front Oncol | 2022 | 36212459 | PubTator, text mining | PubMed |
| Prognostic characteristics of immune subtypes associated with acute myeloid leukemia and their identification in cell subsets based on single-cell sequencing analysis. | Front Cell Dev Biol | 2022 | 36211454 | PubTator, text mining | PubMed |
| Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment. | Front Immunol | 2022 | 36211436 | PubTator, text mining | PubMed |
| Characterization of placental and decidual cell development in early pregnancy loss by single-cell RNA sequencing. | Cell Biosci | 2022 | 36209198 | PubTator, text mining | PubMed |
| Effect of FOXP2 transcription factor on immune infiltration of thyroid cancer and its potential clinical value. | Front Immunol | 2022 | 36203616 | PubTator, text mining | PubMed |
| Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. | NPJ Genom Med | 2022 | 36198672 | PubTator, text mining | PubMed |
| HCV and tumor-initiating stem-like cells. | Front Physiol | 2022 | 36187761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=34